Navigation Links
QuikByte Software, Inc. Announces Changes to Board of Directors and Executive Ranks
Date:7/7/2008

MIAMI, July 7 /PRNewswire-FirstCall/ -- QuikByte Software, Inc. (OTC Bulletin Board: QBYT) today announced the following changes to its Board of Directors and executive leadership:

Mr. Glenn L. Halpryn was appointed the Chairman, President and Chief Executive Officer of the Company, Mr. Alan Jay Weisberg was appointed the Chief Financial and Accounting Officer and a director of the Company, Mr. Noah M. Silver was appointed the Vice President, Secretary, Treasurer and a director of the Company, and Dr. Curtis Lockshin and Mr. Ronald Stein were each appointed directors of the Company.

The prior directors and officers of the Company resigned before the effectiveness of the appointments.

The appointments and resignations were made in connection with the sale by certain of the Company's shareholders of approximately 94% of the issued and outstanding shares of the Company's common stock to various investors, including Messrs. Halpryn, Weisberg, Silver and Stein. Following the sale, the Company's largest shareholder is Mr. Steven Jerry Glauser, a Denver-based investor. Additional information regarding these transactions is available in QuikByte's reports filed with the Securities and Exchange Commission, which may be accessed at sec.gov/edgar.shtml.

QuikByte Software, Inc. is a "shell company" with no operating assets or business. The Company's plan of business is to identify and evaluate a merger or other business combination with an operating company. No assurance can be given as to when or if the Company will be successful in doing so.

Forward Looking Statements:

This release contains "forward-looking statements," as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA). Actual results may differ from those projected due to a number of risks and uncertainties, including, but not limited to the possibility that some or all of the pending matters and transactions considered by QuikByte Software, Inc. may not proceed as contemplated, and by all other matters specified in the QuikByte's filings with the Securities and Exchange Commission. These statements are made based upon current expectations that are subject to risk and uncertainty. QuikByte does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in QuikByte's filings with the Securities and Exchange Commission, including its most recent periodic report. We intend that all forward-looking statements be subject to the safe-harbor provisions of the PSLRA.


'/>"/>
SOURCE QuikByte Software, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. March of Dimes Announces Nursing Scholarship Recipients
2. Zix Corporation Announces Webcast Showcasing Email Encryption Competitive Replacement
3. Digestive Care, Inc. Announces the Filing of the First Module of NDA Submission for PANCRECARB(R) (pancrelipase)
4. Mindray Announces 20-F Filing
5. Mergent, Inc. Announces Changes to the HealthShares(TM) Ophthalmology Index
6. Senetek Announces Termination of Invicorp(R) License Agreement With Ardana Bioscience Limited
7. Mylan Announces Tentative FDA Approval for Generic Version of Antibiotic Zyvox(R) Tablets
8. Hooper Holmes Announces Sale of Claims Evaluation Division
9. Transition Therapeutics Announces Executive Management Appointments
10. Chindex International, Inc. Announces Receipt of Key Regulatory ApprovalsChina SFDA Certificates Received Include Intuitive Surgical daVinci S
11. Ambulatory Services of America, Inc. Announces the Acquisition of Dialysis Operations in St. Louis, Missouri
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... , ... January 21, 2017 , ... Seamild, the largest ... the futuristic vision of its owner and founder. As Oat is recognized globally as ... everybody he knows personally as he believes it is a move to sow the ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... ... of Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual ... alumni, family, friends, and community. “Coming Home 2017” will be held on ...
(Date:1/21/2017)... ... January 21, 2017 , ... Santa Rosa Orthopaedics (SRO) ... located at 167 Lynch Creek Way. The Petaluma office features three comfortable patient ... and rehabilitation services and on-site x-ray services. Two multi-specialist orthopaedic surgeons Dr. ...
(Date:1/21/2017)... ... 2017 , ... The Nobel Biocare™ dental implant company is ... its creos™ line of bone regenerative products. Specifically, the Nobel Biocare™ ... creos™ allo.gain™ bone graft for a variety of bone reconstruction procedures. In addition ...
(Date:1/20/2017)... ... January 20, 2017 , ... A new partnership between ... they no longer use or need, from clothes to couches to dressers and bicycles. ... and take them to the nearest Goodwill donation center through February 28th. , ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... Research and Markets has announced the addition of ... BUN Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive Metabolic Panel, Liver Panel, ... 2024" report to their offering. ... The global clinical laboratory testing market is ... of innovative solutions on the grounds of maximum efficiency and minimum ...
(Date:1/20/2017)... BUFFALO, N.Y. , Jan. 20, 2017 /PRNewswire/ ... health programs, has announced the launch of an ... to new guidelines on opioids and helps stem ... Opioids are often prescribed to treat chronic non-cancer ... disease) despite serious risks and lack of evidence ...
(Date:1/19/2017)... NEW YORK , Jan. 19, 2017 /PRNewswire/ ... reach USD 233.7 billion by 2025, according to ... The market is anticipated to be predominantly driven ... companies, resulting into the large-scale production of new ... widen the influx of drugs at an unprecedented ...
Breaking Medicine Technology: